Chronos Archive seal

Review checklist: Fannie Lou Hamer (HR-ML031)

All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments

Everything a reviewer needs to judge, gathered from the record. Release status: draft.

Review status

ReviewStatusReviewerDateNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the confirmation of hypertension by home readings, the CKD G2 A2 classification with a scarred kidney, the single-pill amlodipine-benazepril, dapagliflozin and its sick-day rules, atorvastatin intensity, the eGFR without a race term, and the consent documentation at each visit.
provenance reviewnot_startedSources: the National Women's History Museum, the SNCC Digital Gateway, PBS, her own 1964 testimony (American RadioWorks), The Conversation, the Equal Justice Initiative, the Mississippi Free Press, WCBI, the UMKC Women's Center, and Fannie Lou Hamer's America. The Smithsonian and Library of Congress pages could not be fetched.
safe messaging reviewnot_startedThe sterilization and the beating are recorded as sensitive, plainly and without graphic detail. No mental health claim is made; mood screening is synthetic and below the threshold for a safety assessment. Her mistrust is presented as earned, and her refusals are respected, not labeled.

Judgment calls (dossier editorial resolutions)

  1. Recent-death rule. Hamer died in 1977, so the rule does not apply. Even so, the case keeps to published accounts and her own testimony, and adds no sick visit, because an acute illness would add nothing to the teaching objective.
  2. Sensitive history. The operation done without her consent (CLM-0003) and the Winona beating and its injuries (CLM-0005, CLM-0006) are marked sensitive. They are stated plainly, without graphic detail, and are used in the modern episode only as she would tell them to a new clinician: in her past medical history, in her stated wish to be told everything first, and in the kidney and eye history. The operation appears in the past surgical history as she described it, with a note that no operative record shows whether the cervix was removed.
  3. What could not be verified and was left out. A childhood illness causing her limp is often repeated but no fetched source stated it, so it is not used; the limp appears only in the synthetic functional status, linked to the documented leg injuries. Her 1964 Washington testimony that six of ten Black women at a local hospital were sterilized is quoted only in secondary sources, so it is not used. The Freedom Farm Cooperative has conflicting founding dates (1967 or 1969) and is not used. A period of exhaustion in the early 1970s is described only on one page with inconsistent dates and would be a mental health claim, so it is not used. The Smithsonian, Library of Congress, Mississippi Encyclopedia and Mississippi legislature pages could not be fetched.
  4. Conflicts. The cause of death is given as complications of hypertension and breast cancer (UMKC Women’s Center), complications of heart disease and cancer (PBS), breast cancer (National Women’s History Museum), and complications of heart disease, diabetes and breast cancer at her last admission (Fannie Lou Hamer’s America, from Brooks); CLM-0009 records them together. One source says she was blinded in one eye and another says a blood clot affected the left eye; the claim keeps both. Her home is given as Ruleville in her 1964 testimony; the plantation is not named in the claims.
  5. Index age and dates. The index visit on March 9, 2026 maps to March 9, 1967, when she was 49: six years after the operation, four years after the beating, and a decade before her death. The synthetic date of birth is October 6, 1976 (shift 59 years). The chronic-care visits on March 23, May 4, July 13 and October 19, 2026, the preventive visit on September 14, 2026 (age 49, so a periodic adult preventive visit), and the mammogram on October 5, 2026 map to the same days of 1967. She turns 50 before the last visit, so the first zoster dose is given then. Past medical history includes only the operation (1961) and the beating (1963).
  6. Synthetic clinical picture. Diabetes, hypertension and kidney disease are documented only at the end of her life; their presence at 49 is synthetic. Following the presenting-problem pattern, the intake records elevated blood pressure (R03.0) and albuminuria (R80.9) as findings to be confirmed, both resolved at two weeks when home readings confirmed hypertension and the ultrasound and repeat test established chronic kidney disease G2 A2 (I12.9, N18.2, E11.22 recorded then). Diabetes is diagnosed at intake because a random glucose of 238 mg/dL with symptoms and an A1c of 8.6% meet the criteria. The small scarred right kidney, the left-eye scarring and reduced acuity, all laboratory values, the ECG, the ultrasound and retinal findings, the medicines and the screening results are synthetic; the kidney and eye findings are chosen to be consistent with the documented injuries. Breast cancer appears only as history (CLM-0008, after the episode) and in screening: the synthetic mammogram at 49 is normal, which does not contradict a lump found in her late fifties. The eGFR uses CKD-EPI 2021 without a race term. Qualitative results (ECG, ultrasound, retinal photographs, mammogram, stool test, HIV, hepatitis C, FIB-4) appear only in note text. Height (163 cm) and weights are synthetic.
  7. Consent as the teaching contrast. Every encounter’s examination begins with a “Consent and chaperone” entry, and each procedure display records that it was explained and agreed. She declines a breast and a pelvic examination at the preventive visit and the refusal is recorded as her choice, with cervical screening marked “declined,” and the offer kept open. Advance care planning records, at her request, that no operation or procedure is to be done without her agreement or her named agent’s.
  8. Access. The team includes a community health worker, a nurse and a pharmacist. Real resources: SNAP, the Low Income Home Energy Assistance Program, 211, the health center’s sliding-fee scale, food pantry and produce program, discount pharmacy, van rides, mobile phlebotomy and telehealth. Medicines are chosen for cost and once-daily dosing (generic metformin extended-release, a single amlodipine-benazepril capsule, generic atorvastatin), with dapagliflozin through the discount pharmacy.
  9. Real people. Her husband is mentioned only as part of her household; her parents appear only in the birth claim; no real person has a role in the modern episode.
  10. Preventive visit. A periodic adult preventive visit at 49 (CPT 99396 with 99497 in plain text). Judgment calls: mammogram every two years from 40, done with a female technologist and the community health worker; a stool immunochemical test rather than colonoscopy under sedation, her choice; HIV and hepatitis C screening once; cervical screening declined, since whether her cervix remains is unknown; zoster deferred until 50; dental care through the health center.
  11. Focused visits. The four chronic-care follow-ups (two weeks with the consultation, eight weeks, four months and seven months) are documented as focused visits on the CMID hypertension, diabetes, hyperlipidemia, chronic kidney disease and depression monographs, the 2025 AHA/ACC guideline, the ADA Standards of Care 2026 and KDIGO 2024, with a consent row at every visit. One deviation is recorded instead of an invented result: the potassium and creatinine check due one to two weeks after starting benazepril and dapagliflozin was missed because she had no ride; the six-week results showed no harm (potassium 4.7 mmol/L, eGFR 73 to 66, a fall of under 10%), and the corrective action was to book rides with each visit, schedule tests on clinic days and use mobile phlebotomy (INT-013). LDL stayed at 80 mg/dL against a goal below 70; she chose not to add a medicine yet, and the goal remains open.
  12. Consultation. The nephrology referral and the telehealth consultation by Cornelius Agbaje, MD (a fictional consultant), on the day of the two-week visit, are S. The consultant answers the six referral questions in line with what the record shows afterwards: chronic kidney disease G2 A2 with a scarred right kidney and diabetic and hypertensive contributions; no further imaging; amlodipine-benazepril with a goal below 130/80 (reached at four months); dapagliflozin with sick-day rules; metformin continued at full dose; potassium and creatinine at one to two weeks (missed, see above) and then every six months; urine albumin at three to four months (52 mg/g, then 41 mg/g); and a telehealth review about increasing benazepril or adding finerenone if albumin stays raised, which the last visit books for the new year.

Protocol deviations

Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.

VisitMeasureIntervalWhat happened
2026-05-04
Progress note 03 (C-CDA)
Potassium, creatinine and eGFROne to two weeks after starting an ACE inhibitor, then every 6 months (more often with changes)Missed: the check planned one to two weeks after starting benazepril and dapagliflozin was not done because she had no ride. No harm judging by today's results (potassium 4.7 mmol/L; creatinine 1.04 mg/dL, eGFR 66, a fall of under 10%). Corrective action: checks scheduled on her clinic days with rides booked in advance, and a home blood draw when no ride can be found

Orders and referrals without results in the record

VisitTypeItemStatusDetail
2026-03-23
Progress note 02 (C-CDA)
LaboratoryPotassium, creatinine and eGFROrderedBenazepril started today; check booked in one to two weeks
2026-09-14
Progress note 05 (C-CDA)
PreventionBreast cancer screeningOrderedMammogram every two years from 40; none before; explained step by step and she agreed; ride and companion arranged
2026-09-14
Progress note 05 (C-CDA)
PreventionColorectal cancer screeningOrderedStool immunochemical test, her choice; kit given today

Evidence to check

Retrospective claims (R)

None.

Sensitive claims

ClaimGradeStatement
CLM-0003DIn 1961, hospitalized for abdominal pain, she was found to have a uterine tumor; during the operation to remove it, a white surgeon performed a hysterectomy without her knowledge or informed consent. She later called this a "Mississippi appendectomy," a name for the sterilizations done without consent to Black women in the South.
CLM-0005DOn June 9, 1963, returning from a voter-registration workshop, she was arrested with other activists in Winona, Mississippi, and in the jail two Black prisoners were ordered by officers to beat her with a blackjack, as she testified the next year.
CLM-0006DThe beating left her with lifelong injuries to her eyes, legs and kidneys: permanent kidney damage, and a blood clot in her left eye with loss of vision in one eye.

Diagnoses not confirmed

None.

Notes to read

Every note in the record, with its type. All clinical content is synthetic.

Abnormal results

DateResultValueFlag
2026-03-09Hemoglobin A1c8.6% (high)High
2026-03-09Glucose (random)238 mg/dL (high)High
2026-03-09eGFR (CKD-EPI 2021)73 mL/min/1.73 m² (low)Low
2026-03-09Urine albumin-to-creatinine ratio88 mg/g (high)High
2026-03-09Total cholesterol228 mg/dL (high)High
2026-03-09LDL cholesterol146 mg/dL (high)High
2026-03-09HDL cholesterol44 mg/dL (low)Low
2026-03-09Triglycerides190 mg/dL (high)High
2026-03-23Urine albumin-to-creatinine ratio96 mg/g (high)High
2026-05-04eGFR (CKD-EPI 2021)66 mL/min/1.73 m² (low)Low
2026-05-04HDL cholesterol46 mg/dL (low)Low
2026-07-13Hemoglobin A1c7.3% (high)High
2026-07-13Urine albumin-to-creatinine ratio52 mg/g (high)High
2026-07-13eGFR (CKD-EPI 2021)67 mL/min/1.73 m² (low)Low
2026-10-19Hemoglobin A1c6.9% (high)High
2026-10-19Urine albumin-to-creatinine ratio41 mg/g (high)High
2026-10-19eGFR (CKD-EPI 2021)69 mL/min/1.73 m² (low)Low